Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis R Borlado

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Carcinogenesis|December 1, 2007
CDC6: from DNA replication to cell cycle checkpoints and oncogenesisLuis R Borlado, Juan Méndez
Circulation Research|December 18, 2012
Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1Laura Lauden, Wahid Boukouaci, Luis R Borlado, et al.
Cell Cycle (Georgetown, Tex.)|December 25, 2015
Deregulated expression of Cdc6 in the skin facilitates papilloma formation and affects the hair growth cycleSabela Búa, Peggy Sotiropoulou, Cecilia Sgarlata, et al.
Proteomics|December 16, 2014
Exploring analytical proteomics platforms toward the definition of human cardiac stem cells receptomePatrícia Gomes-Alves, Margarida Serra, Catarina Brito, et al.
Cardiovascular Research|September 13, 2014
Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistenceWahid Boukouaci, Laura Lauden, Johan Siewiera, et al.
Scientific Reports|April 22, 2021
Mechanistic and therapeutic distinctions between cardiosphere-derived cell and mesenchymal stem cell extracellular vesicle non-coding RNAAnn-Sophie Walravens, Sasha Smolgovsky, Liang Li, et al.
Scientific Reports|October 21, 2017
Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cellsHocine R Hocine, Hicham El Costa, Noemie Dam, et al.
Scientific Reports|January 25, 2017
Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cellsHocine R Hocine, Hicham E L Costa, Noemie Dam, et al.
Scientific Reports|October 4, 2017
CXCL6 is an important paracrine factor in the pro-angiogenic human cardiac progenitor-like cell secretomeJosé Luis Torán, Susana Aguilar, Juan Antonio López, et al.
Circulation Research|May 24, 2017
Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction)Ricardo Sanz-Ruiz, Ana Casado Plasencia, Luis R Borlado, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Carcinogenesis|December 1, 2007
CDC6: from DNA replication to cell cycle checkpoints and oncogenesisLuis R Borlado, Juan Méndez
Circulation Research|December 18, 2012
Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1Laura Lauden, Wahid Boukouaci, Luis R Borlado, et al.
Cell Cycle (Georgetown, Tex.)|December 25, 2015
Deregulated expression of Cdc6 in the skin facilitates papilloma formation and affects the hair growth cycleSabela Búa, Peggy Sotiropoulou, Cecilia Sgarlata, et al.
Proteomics|December 16, 2014
Exploring analytical proteomics platforms toward the definition of human cardiac stem cells receptomePatrícia Gomes-Alves, Margarida Serra, Catarina Brito, et al.
Cardiovascular Research|September 13, 2014
Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistenceWahid Boukouaci, Laura Lauden, Johan Siewiera, et al.
Scientific Reports|April 22, 2021
Mechanistic and therapeutic distinctions between cardiosphere-derived cell and mesenchymal stem cell extracellular vesicle non-coding RNAAnn-Sophie Walravens, Sasha Smolgovsky, Liang Li, et al.
Scientific Reports|October 21, 2017
Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cellsHocine R Hocine, Hicham El Costa, Noemie Dam, et al.
Scientific Reports|January 25, 2017
Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cellsHocine R Hocine, Hicham E L Costa, Noemie Dam, et al.
Scientific Reports|October 4, 2017
CXCL6 is an important paracrine factor in the pro-angiogenic human cardiac progenitor-like cell secretomeJosé Luis Torán, Susana Aguilar, Juan Antonio López, et al.
Circulation Research|May 24, 2017
Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction)Ricardo Sanz-Ruiz, Ana Casado Plasencia, Luis R Borlado, et al.
Pageof 2